These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948 [TBL] [Abstract][Full Text] [Related]
24. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM; Sahin S; Kantarci G; Ergin H Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308 [TBL] [Abstract][Full Text] [Related]
25. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508 [TBL] [Abstract][Full Text] [Related]
26. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674 [TBL] [Abstract][Full Text] [Related]
27. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675 [TBL] [Abstract][Full Text] [Related]
28. Polyomavirus nephropathy after renal transplantation: a single centre experience. Kim HC; Hwang EA; Han SY; Park SB; Park KK Nephrology (Carlton); 2005 Apr; 10(2):198-203. PubMed ID: 15877682 [TBL] [Abstract][Full Text] [Related]
29. Chronic cyclosporin-induced nephropathy. Takahara S; Ota K; Takahashi K; Uchida K; Morozumi K; Wang JD; Kyo M; Clin Nephrol; 2001 Jan; 55(1):69-72. PubMed ID: 11200870 [TBL] [Abstract][Full Text] [Related]
30. Electron microscopic peritubular capillary lesions: a new criterion for chronic rejection. Oikawa T; Morozumi K; Koyama K; Takeuchi O; Takeda A; Uchida K; Fujinami T Clin Transplant; 1999; 13 Suppl 1():24-32. PubMed ID: 10751053 [TBL] [Abstract][Full Text] [Related]
31. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041 [TBL] [Abstract][Full Text] [Related]
32. The renal allograft donor with isolated microhematuria. Karkar A Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):316-9. PubMed ID: 16970250 [TBL] [Abstract][Full Text] [Related]
33. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era. Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870 [TBL] [Abstract][Full Text] [Related]
34. [Pathologic diagnosis of renal transplantation]. Kondo N Rinsho Byori; 1990 Feb; 38(2):169-74. PubMed ID: 2329720 [TBL] [Abstract][Full Text] [Related]
35. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients. Baboolal K Transplantation; 2003 Apr; 75(8):1404-8. PubMed ID: 12717239 [TBL] [Abstract][Full Text] [Related]
36. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
37. Utility of biopsy in kidney transplants with delayed graft function and acute dysfunction. Silva DM; Garcia JP; Ribeiro AR; Veronese FJ; Edelweiss MI; Gonçalves LF; Manfro RC Transplant Proc; 2007 Mar; 39(2):376-7. PubMed ID: 17362734 [TBL] [Abstract][Full Text] [Related]
38. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy. Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakamoto S; Yoshimura N Transplant Proc; 2009; 41(1):446-9. PubMed ID: 19249577 [TBL] [Abstract][Full Text] [Related]
39. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657 [TBL] [Abstract][Full Text] [Related]
40. Benefits of early biopsy on the outcome of kidney transplantation. Dominguez J; Kompatzki A; Norambuena R; Arenas J; Dell'Oro A; Bustamante A; Pinochet R; Cabello JM; Alvarez S; Pais E; Llanos R; Cortes-Monroy G Transplant Proc; 2005 Oct; 37(8):3361-3. PubMed ID: 16298596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]